Form 4 for AMPH Amphastar Pharmaceuticals, Inc.
Accepted 2025-03-18 00:00:00 ET · period of report 2025-03-15 · accession 0001415889-25-008500 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| M | 2025-03-18 | 2025-03-15+ | AMPH | Liawatidewi Yakob | EVP CORP ADMIN CENTER, Dir | F - Tax | $27.31 | -2,762 | 92.6K | -3% | -$75.4K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2025-03-17 | F | D | 1,731 | $27.69 | 90,909 | D | — | — | (F1) The reported shares were withheld to satisfy the reporting person's tax liability in connection with the vesting of restricted stock units, or RSUs. |
| 2 | Common | Common Stock | 2025-03-15 | F | D | 1,031 | $26.66 | 92,640 | D | — | — | (F1) The reported shares were withheld to satisfy the reporting person's tax liability in connection with the vesting of restricted stock units, or RSUs. |